Search for 'Provider:Oncotarget,'

A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.

Place Hold on A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.

Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile.

By Martínez Sánchez, María Pilar. Oncotarget, 2015 . 6(22):19204-16. , Formato Vancouver: Martín Martín L, López A, Vidriales B, Caballero MD, Rodrigues AS, Ferreira SI et al. Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile. Oncotarget. 2015 Aug 7;6(22):19204-16.

Place Hold on Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile.

Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis.

By Page, Angustias | Saiz Ladera, Cristina | Paramio, Jesús M.. Oncotarget, 2015 . 6(15):12920-35. , Formato Vancouver: Zur R, García Ibánez L, Núñez Buiza A, Aparicio N, Liappas G, Escós A et al. Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis. Oncotarget. 2015 May 30;6(15):12920-35.

Place Hold on Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis.

Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma.

By Hernández Laín, Aurelio. Oncotarget, 2015 . 6(13):10950-63. , Formato Vancouver: González Gómez P, Crecente Campo J, Zahonero C, de la Fuente M, Hernández Laín A, Mira H et al. Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma. Oncotarget. 2015 May 10;6(13):10950-63.

Place Hold on Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma.

Enhanced tumorigenicity by mitochondrial DNA mild mutations.

By Cruz Bermúdez, Alberto | Gallardo, María Esther | Fernández Moreno, Miguel Ángel | Garesse, Rafael. Oncotarget, 2015 . 6(15):13628-43. , Formato Vancouver: Cruz Bermúdez A, Vallejo CG, Vicente Blanco RJ, Gallardo ME, Fernández Moreno MÁ, Quintanilla M et al. Enhanced tumorigenicity by mitochondrial DNA mild mutations. Oncotarget. 2015 May 30;6(15):13628-43.

Place Hold on Enhanced tumorigenicity by mitochondrial DNA mild mutations.

Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.

By Ortiz Romero, Pablo Luis. Oncotarget, 2015 . 6(28):25452-65. , Formato Vancouver: Curiel Olmo S, García Castaño A, Vidal R, Pisonero H, Varela I, León Castillo A et al. Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures. Oncotarget. 2015 Sep 22;6(28):25452-65.

Place Hold on Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.

RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development.

By Riveiro Falkenbach, Erica | Ortiz Romero, Pablo Luis | Rodríguez Peralto, José Luis. Oncotarget, 2015 . 6(14):11848-62. , Formato Vancouver: Alonso Curbelo D, Osterloh L, Cañón E, Calvo TG, Martínez Herranz R, Karras P et al. RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development. Oncotarget. 2015 May 20;6(14):11848-62.

Place Hold on RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development.

Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer.

By Grávalos Castro, Cristina. Oncotarget, 2015 . 6(8):6422-30. , Formato Vancouver: García González X, Cortejoso L, García MI, García Alfonso P, Robles L, Grávalos C et al. Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer. Oncotarget. 2015 Mar 20;6(8):6422-30.

Place Hold on Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer.

A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.

By Martínez López, Joaquín. Oncotarget, 2016 . 7(37):59029-48. , Formato Vancouver: Ríos Tamayo R, Lupiañez CB, Campa D, Hielscher T, Weinhold N, Martínez López J et al. A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis. Oncotarget. 2016 Sep 13;7(37):59029-48.

Place Hold on A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.

Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer.

By Andradas, Clara | Blasco Benito, Sandra | Pérez Gómez, Eduardo | Sánchez, Cristina. Oncotarget, 2016 . 7(30):47565-75. , Formato Vancouver: Andradas C, Blasco Benito S, Castillo Lluva S, Dillenburg Pilla P, Diez Alarcia R, Juanes García A et al. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer. Oncotarget. 2016 Jul 26;7(30):47565-47575.

Place Hold on Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer.

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.

By Molina Pinelo, Sonia | Paz-Ares Rodríguez, Luis. Oncotarget, 2016 . 7(33):52849-52861. , Formato Vancouver: Usó M, Jantus Lewintre E, Bremnes RM, Calabuig S, Blasco A, Pastor E et al. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers. Oncotarget. 2016 Aug 16;7(33):52849-52861.

Place Hold on Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.

Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer.

By Alameda, Josefa P | Ramírez, Ángel | Navarro, Manuel | Page, Angustias | Suárez Cabrera, Cristian | Paramio, Jesús M. | Llanos Casanova, M. Oncotarget, 2016 . 7(20):29531-47. , Formato Vancouver: Alameda JP, Gaspar M, Ramírez Á, Navarro M, Page A, Suárez Cabrera C et al. Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer. Oncotarget. 2016 May 17;7(20):29531-47.

Place Hold on Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer.

Deregulation of the pRb-E2F4 axis alters epidermal homeostasis and favors tumor development.

By Santos, Mirentxu | Martínez Fernández, Mónica | Lorz, Corina | Paramio, Jesús M.. Oncotarget, 2016 . 7(46):75712-28. , Formato Vancouver: Costa C, Santos M, Martínez Fernández M, Lorz C, Lázaro S, Paramio JM. Deregulation of the pRb-E2F4 axis alters epidermal homeostasis and favors tumor development. Oncotarget. 2016 Nov 15;7(46):75712-28.

Place Hold on Deregulation of the pRb-E2F4 axis alters epidermal homeostasis and favors tumor development.

Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state.

By Santacatterina, Fulvio | Sánchez Cenizo, Laura | Formentini, Laura | Casas, Estela | Martínez Reyes, Inmaculada | García Bermúdez, Javier | Sánchez Aragó, María | Satrústegui, Jorgina | Cuezva, J.M.. Oncotarget, 2016 . 7(1):490-508. , Formato Vancouver: Santacatterina F, Sánchez Cenizo L, Formentini L, Mobasher MA, Casas E, Rueda CB et al. Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state. Oncotarget. 2016 Jan 5;7(1):490-508.

Place Hold on Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state.